Sera from early-onset, severely preeclamptic women directly modulate HLA-E expression in the EA.hy296 endothelial cell line

Journal of Reproductive Immunology

Volumn 104-105, Issue C, 2014, Pages 68-79

  Bueno Sanchez J C ^a   Pena Alzate S ^a   Pena R B ^a   Agudelo Jaramillo, B ^a,b   Cadavid Jaramillo, A P ^a   Chaouat, G ^c   Maldonado Estrada, J G ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b Hospital General de Medellin Luz Castro de Gutierrez ESE   (Colombia)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

Early onset severe preeclampsia; Endothelial cells; HLA E; Systemic inflammatory response syndrome

Indexed keywords

ALPHA GLOBULIN; GAMMA INTERFERON; HLA E ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SERUM ALBUMIN; TUMOR NECROSIS FACTOR ALPHA; HLA ANTIGEN CLASS 1; HLA-E ANTIGEN; IFNG PROTEIN, HUMAN;

ARTICLE; CHORIOCARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; OLIGURIA; ONCOTIC PRESSURE; PREECLAMPSIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEINURIA; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; SYSTOLIC BLOOD PRESSURE; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; BIOSYNTHESIS; BLOOD; CLINICAL TRIAL; DRUG EFFECTS; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; PREGNANCY; SERUM; SEVERITY OF ILLNESS INDEX; TUMOR CELL LINE;

CELL LINE, TUMOR; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON-GAMMA; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; SERUM; SEVERITY OF ILLNESS INDEX;

EID: 84930006150     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2014.03.004     Document Type: Article

References (70)

1. Afzal-Ahmed I., Mann G.E., Shennan A.H., Poston L., Naftalin R.J. Preeclampsia inactivates glucose-6-phosphate dehydrogenase and impairs the redox status of erythrocytes and fetal endothelial cells. Free Radic. Biol. Med. 2007, 42:1781-1790.
2. Ahn H., Park J., Gilman-Sachs A., Kwak-Kim J. Immunologic characteristics of preeclampsia, a comprehensive review. Am. J. Reprod. Immunol. 2011, 65:377-394.
3. Bainbridge D.R., Ellis S.A., Sargent I.L. The short forms of HLA-G are unlikely to play a role in pregnancy because they are not expressed at the cell surface. J. Reprod. Immunol. 2000, 47:1-16.
4. Benoit J., Rey É. Preeclampsia: should plasma albumin level be a criterion for severity?. J. Obstet. Gynaecol. Can. 2011, 33:922-926.
5. Bischof P., Irminger-Finger I. The human cytotrophoblastic cell, a mononuclear chameleon. Int. J. Biochem. Cell Biol. 2005, 37:1-16.
6. Borzychowski A.M., Croy B.A., Chan W.L., Redman C.W.G., Sargent I.L. Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells. Eur. J. Immunol. 2005, 35:3054-3063.
7. Borzychowski A.M., Sargent I.L., Redman C.W. Inflammation and pre-eclampsia. Semin. Fet. Neonat. Med. 2006, 11:309-316.
8. Bouman A., Moes H., Heineman M.J., De Leij L.F., Faas M.M. The immune response during the luteal phase of the ovarian cycle: increasing sensitivity of human monocytes to endotoxin. Fertil. Steril. 2001, 76:555-559.
9. Braud V.M., King A., Allan D.S., Bowen M., Powis S.J., Joseph S., Verma S., Hiby S.E., McMichael A.J., Loke Y.W. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur. J. Immunol. 2000, 30:1623-1631.
10. Bueno-Sánchez J.C., Agudelo-Jaramillo B., Escobar-Aguilerae L.F., Lopera A., Cadavid-Jaramillo A.P., Chaouat G., Maldonado-Estrada J.G. Cytokine production by non-stimulated peripheral blood NK cells and lymphocytes in early-onset severe pre-eclampsia without HELLP. J. Reprod. Immunol. 2013, 97:223-231.
11. Collins T.J. Image J for microscopy. BioTechniques 2007, 43:25-30.
12. Coupel S., Moreau A., Hamidou M., Horejsi V., Soulillou J.-P., Charreau B. Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood 2007, 109:2014-2806.
13. Cramer L. Fluorescence Procedures for the Actin and Tubulin Cytoskeleton in Fixed Cells 1996, http://mitchison.med.harvard.edu/protocols/general.
14. Damle N.K., Doyle L.V. IL-2-activated human killer lymphocytes but not their secreted products mediate increase in albumin flux across cultured endothelial monolayers. Implications for vascular leak syndrome. J. Immunol. 1989, 142:2660-2669.
15. Derré L., Corvaisier M., Charreau B., Moreau A., Godefroy E., Moreau-Aubry A., Jotereau F., Gervois N. Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells. J. Immunol. 2006, 177:3100-3107.
16. Edgell C.J., McDonald C.C., Graham J.B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Nat. Acad. Sci. U. S. A. 1983, 80:3734-3737.
17. Emeis J.J., Edgell C.J. Fibrinolytic properties of a human endothelial hybrid cell line (Ea.hy 926). Blood 1988, 71:1669-1675.
18. Germain S.J., Sacks G.P., Sooranna S.R., Soorana S.R., Sargent I.L., Redman C.W. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J. Immunol. 2007, 178:5949-5956.
19. Gilstrap L., Ramin S. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet. Gynecol. 2002, 99:159-167.
20. Gojnic M., Petkovic S., Papic M., Mostic T., Jeremic K., Vilendecic Z., Djordjevic S. Plasma albumin level as an indicator of severity of preeclampsia. Clin. Exp. Obstet. Gynecol. 2004, 31:209-210.
21. Gu Y., Lewis D.F., Zhang Y., Groome L.J., Wang Y. Increased superoxide generation and decreased stress protein Hsp90 expression in human umbilical cord vein endothelial cells (HUVECs) from pregnancies complicated by preeclampsia. Hypertens. Pregnancy 2006, 25:169-182.
22. Hackmon R., Koifman A., Hyodo H., Glickman H., Sheiner E., Geraghty D.E. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. Am. J. Obstet. Gynecol. 2007, 197(25):e1-e5.
23. Henao D.E., Arias L.F., Mathieson P.W., Ni L., Welsh G.I., Bueno J.C., Agudelo B., Cadavid A.P., Saleem M.A. Preeclamptic sera directly induce slit-diaphragm protein redistribution and alter podocyte barrier-forming capacity. Nephron Exp. Nephrol. 2008, 110:e73-e81.
24. Hung T.-H., Charnock-Jones D.S., Skepper J.N., Burton G.J. Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am. J. Pathol. 2004, 164:1049-1061.
25. Ishitani A., Sageshima N., Hatake K. The involvement of HLA-E and -F in pregnancy. J. Reprod. Immunol. 2006, 69:101-113.
26. Ishitani A., Shobu T., Sageshima N., Tokui H., Omura M., Saito K., Nagatsuka Y., Nakanishi M., Hayashi Y., Hatake K. The surface expression of HLA-F on decidual trophoblasts increases from mid to term gestation. J. Reprod. Immunol. 2006, 72:18-32.
27. Kalkunte S., Boij R., Norris W., Friedman J., Lai Z., Kurtis J., Lim K.H., Padbury J.F., Matthiesen L., Sharma S. Sera from preeclampsia patients elicit symptoms of human disease in mice and provide a basis for an in vitro predictive assay. Am. J. Pathol. 2010, 177:2387-2398.
28. Kanasaki K., Kalluri R. The biology of preeclampsia. Kidney Int. 2009, 76:831-837.
29. Kang J.H., Song H., Yoon J.A., Park D.Y., Kim S.H., Lee K.J., Farina A., Cho Y.K., Kim Y.N., Park S.W., Kim G.J., Shim S.H., Cha D.H. Preeclampsia leads to dysregulation of various signaling pathways in placenta. J. Hypertens. 2011, 29:928-936.
30. Kaufmann P., Black S., Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol. Reprod. 2003, 69:1-7.
31. Kopcow H.D., Karumanchi S.A. Angiogenic factors and natural killer (NK) cells in the pathogenesis of preeclampsia. J. Reprod. Immunol. 2007, 76:23-29.
32. Lee N., Goodlett D.R., Ishitani A., Marquardt H., Geraghty D.E. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 1998, 160:4951-4960.
33. Lilienfeld B.G., Crew M.D., Forte P., Baumann B.C., Seebach J.D. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity. Xenotransplantation 2007, 14:126-134.
34. Lim Y.-C., Garcia-Cardena G., Allport J.R., Zervoglos M., Connolly A.J., Gimbrone M.A., Luscinskas F.W. Heterogeneity of endothelial cells from different organ sites in T-cell subset recruitment. Am. J. Pathol. 2003, 162:1591-1601.
35. Lu Z.J., Ren Y.Q., Wang G.P., Song Q., Li M., Jiang S.S., Ning T., Guan Y.S., Yang J.L., Luo F. Biological behaviors and proteomics analysis of hybrid cell line EAhy926 and its parent cell line A549. J. Exp. Clin. Cancer Res. 2009, 28:16.
36. Lunghi L., Ferretti M.E., Medici S., Biondi C., Vesce F. Control of human trophoblast function. Reprod. Biol. Endocrinol. 2007, 5:6.
37. Margarson M.P., Soni N. Serum albumin: touchstone or totem?. Anaesthesia 1998, 53:789-803.
38. Meekins J.W., Luckas M.J., Pijnenborg R., McFadyen I.R. Histological study of decidual spiral arteries and the presence of maternal erythrocytes in the intervillous space during the first trimester of normal human pregnancy. Placenta 1997, 18:459-464.
39. Mouillot G., Marcou C., Zidi I., Guillard C., Sangrouber D., Carosella E.D., Moreau P. Hypoxia modulates HLA-G gene expression in tumor cells. Hum. Immunol. 2007, 68:277-285.
40. Nematbakhsh M., Moradi A., Khazaei M., Jafari S. Mathematical model for determination of colloid osmotic pressure: the role of albumin-globulin ratio. J. Res. Med. Sci. 2006, 11:364-369.
41. Nisell H., Trygg M., Bäck R. Urine albumin/creatinine ratio for the assessment of albuminuria in pregnancy hypertension. Acta Obst. Gynecol. Scand. 2006, 85:1327-1330.
42. Ogge G., Chaiworapongsa T., Romero R., Hussein Y., Kusanovic J.P., Yeo L., Kim C.J., Hassan S.S. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J. Perinatal Med. 2011, 39:641-652.
43. Pecks U., Schütt A., Röwer C., Reimer T., Schmidt M., Preschany S., Stepan H., Rath W., Glocker M.O. A mass spectrometric multicenter study supports classification of preeclampsia as heterogeneous disorder. Hypertens. Pregnancy 2012, 31:278-291.
44. Peng B., Zhang L., Xing A.-Y., Hu M., Liu S. The expression of human leukocyte antigen G and E on human first trimester placenta and its relationship with recurrent spontaneous abortion. Sichuan Da Xue Xue Bao. Yi Xue Ban 2008, 39(6):976-979.
45. Poston L. Endothelial dysfunction in pre-eclampsia. Pharmacol. Rep. 2006, 58(Suppl.):69-74.
46. Rabreau M., Larrad M.L., Pla M., Carosella E.D., Rouas-Freiss N., Menier C., Saez B., Horejsi V., Martinozzi S., Krawice-Radanne I., Bruel S., Le Danff C., Reboul M., Hilgert I. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules. Hum. Immunol. 2003, 64:315-326.
47. Rebmann V., LeMaoult J., Rouas-Freiss N., Carosella E.D., Grosse-Wilde H. Quantification and identification of soluble HLA-G isoforms. Tissue Antigens 2007, 69(Suppl. 1):143-149.
48. Redman C.W.G., Tannetta D.S., Dragovic R., a, Gardiner C., Southcombe J.H., Collett G.P., Sargent I.L. Review: Does size matter? Placental debris and the pathophysiology of pre-eclampsia. Placenta 2012, 33(Suppl.):S48-S54.
49. Reis Z.S.N., Lage E.M., Teixeira P.G., Porto L.B., Guedes L.R., Oliveira E.C.L.de, Cabral A.C.V. Early-onset preeclampsia: is it a better classification for maternal and perinatal outcomes?. Rev. Bras. Ginecol. Obstet. 2010, 32:584-590.
50. Risberg A., Larsson A., Olsson K., Lyrenäs S., Sjöquist M. Relationship between urinary albumin and albumin/creatinine ratio during normal pregnancy and pre-eclampsia. Scand. J. Clin. Lab. Invest. 2004, 64:17-23.
51. Robillard P.-Y., Chaouat G., Le Bouteiller P., Fournier T., Barau G., Roman H., Heisert M., Dekker G., Hulsey T.-C., Vaiman D., Foidart J.-M., Boukerrou M. Current debates on immunology of preeclampsia. Report of the sixth international workshop of Reunion Island (Indian Ocean, December 2008). Gynécol. Obstét. Fertil. 2009, 37:570-578.
52. Saito S., Sakai M., Sasaki Y., Nakashima A., Shiozaki A. Inadequate tolerance induction may induce pre-eclampsia. J. Reprod. Immunol. 2007, 76:30-39.
53. Saito S., Shiozaki A., Nakashima A., Sakai M., Sasaki Y. The role of the immune system in preeclampsia. Mol. Aspects Med. 2007, 28:192-209.
54. Schiessl B. Inflammatory response in preeclampsia. Mol. Aspects Med. 2007, 28:210-219.
55. Shaikly V., Shakhawat A., Withey A., Morrison I., Taranissi M., Dealtry G.B., Jabeen A., Cherry R., Fernández N. Cell bio-imaging reveals co-expression of HLA-G and HLA-E in human preimplantation embryos. Reprod. Biomed. Online 2010, 20:223-233.
56. Sibai B.M. Diagnosis and Management of Gestational Hypertension and Preeclampsia. Obstet. Gynecol. 2003, 102:181-192.
57. Sibai B.M. Imitators of severe pre-eclampsia. Semin. Perinatol. 2009, 33:196-205.
58. Sibai B., Dekker G., Kupferminc M. Pre-eclampsia. Lancet 2005, 365:785-799.
59. Silva Z., Tong Z., Cabral M.G., Martins C., Castro R., Reis C., Trindade H., Konstantopoulos K., Videira P.A. Sialyl Lewisx-dependent binding of human monocyte-derived dendritic cells to selectins. Biochem. Biophys. Res. Commun. 2011, 409:459-464.
60. Steinborn A., Varkonyi T., Scharf A., Bahlmann F., Klee A., Sohn C. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. Am. J. Reprod. Immunol. 2007, 57:277-286.
61. Sullivan L.C., Hoare H.L., McCluskey J., Rossjohn J., Brooks A.G. A structural perspective on MHC class Ib molecules in adaptive immunity. Trends Immunol. 2006, 27:413-420.
62. Sullivan L.C., Clements C.S., Rossjohn J., Brooks A.G. The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity. Tissue Antigens 2008, 72:415-424.
63. Van der Meer A., Lukassen H.G.M., Van Cranenbroek B., Weiss E.H., Braat D.D.M., Van Lierop M.J., Joosten I., Meer A., Van Der, Cranenbroek B., Van Lierop M.J. Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells. Mol. Hum. Reprod. 2007, 13:123-133.
64. Van Nieuwenhoven A.L.V., Moes H., Heineman M.J., Santema J., Faas M.M. Cytokine production by monocytes, NK cells, and lymphocytes is different in preeclamptic patients as compared with normal pregnant women. Hypertens. Pregnancy 2008, 27:207-224.
65. Vásquez Rodríguez J.G. Plasma colloid osmotic pressure, Briones index and ascites in preeclampsia-eclampsia. Cir. Cir. 2010, 78:137-143.
66. Von Dadelszen P., Hurst G., Redman C.W. Supernatants from co-cultured endothelial cells and syncytiotrophoblast microvillous membranes activate peripheral blood leukocytes in vitro. Hum. Reprod. 1999, 14:919-924.
67. Wang X., Li B., Wang J., Lei J., Liu C., Ma Y., Zhao H. Evidence that miR-133a causes recurrent spontaneous abortion by reducing HLA-G expression. Reprod. Biomed. Online 2012, 25:415-424.
68. Wei J., Satomi M., Negishi Y., Matsumura Y., Miura A., Nishi Y., Asakura H., Takeshita T. Effect of sera on the adhesion of natural killer cells to the endothelium in severe pre-eclampsia. J. Obstet. Gynaecol. Res. 2006, 32:443-448.
69. Zen K., Cui L.-B., Zhang C.-Y., Liu Y. Critical role of mac-1 Sialyl Lewis x moieties in regulating neutrophil degranulation and transmigration. J. Mol. Biol. 2007, 374:54-63.
70. Zhang Z., Lu B., Ni H., Sheng X., Jin N. Prediction of pulmonary edema by plasma protein levels in patients with sepsis. J. Crit. Care 2012, 27:623-629.